http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2014005635-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
filingDate 2012-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd376962026f7dbeccd45d1c84bd7298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46726b1c0e469e7b3edc3890e5e1e5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e981e654f858d5338c4c1d9216548872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e520ac5f570244e0e49bf70656fa9db9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_136edf795e06da10af529124593542d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81f766c13e234225bb10cec9bb4fe438
publicationDate 2014-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2014005635-A
titleOfInvention DERIVATIVES OF 2 - (1,2,3 -TRIAZOL - 2 - IL) BENZAMIDA AND 3 - (1,2,3 - TRIAZOL - 2 - IL) PICOLINAMIDE.
abstract The present invention relates to derivatives of 2- (1,2,3-triazol-2-yl) benzamide and 3- (1,2,3-triazol-2-iI) picolinam of the formula (I): ( see Formula) where Ar1, Q and R1 through R5 are defined as described in the description; to its preparation; to its pharmaceutically acceptable salts; and its use as pharmaceutical products; to pharmaceutical compositions containing one or more compounds of the formula (I); and especially, to its use as orexin receptor antagonists.
priorityDate 2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420569501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69410274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433472287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89558903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138555637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431135847

Total number of triples: 38.